Angiotensin-converting enzyme inhibitors--when to use?

Area of Science:

• Cardiology
• Pharmacology

Background:

• Defining and quantifying heart failure presents challenges in evaluating drug efficacy.
• The role of angiotensin-converting enzyme (ACE) inhibitors in heart failure management is debated.

Purpose of the Study:

• To assess the relative value of different drug regimens for heart failure.
• To clarify the specific benefits of ACE inhibitors in heart failure.

Main Methods:

• Review of theoretical considerations and practical clinical observations regarding ACE inhibitors.
• Comparison of ACE inhibitors with diuretics and general vasodilators in heart failure treatment.

Main Results:

• ACE inhibitors provide significant relief for patients with severe heart failure.
• In moderately ill patients, ACE inhibitors may be less effective than intensified diuretic therapy.
• Vasodilators, including ACE inhibitors, may reduce heart failure mortality, but this effect is not exclusive to ACE inhibitors.

Conclusions:

• The utility of ACE inhibitors in heart failure varies with disease severity.
• Optimizing diuretic therapy may be as effective as ACE inhibitors in moderate heart failure.
• The benefits of vasodilators in heart failure are broader than just ACE inhibitors.